|
Pivovarov D.V., Mikhailova Z.D.
Application of kidney injury molecule-1 (KIM-1) for predicting urgent cardiovascular complications in acute cardiorenal syndrome
|
№1 / 2024
|
|
I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, Zh.A. Murkamilova, F.A. Yusupov, I.O. Kudaibergenova
Homocystein and folic acid in chronic kidney disease: clinical and predictive significance
|
№3 / 2021
|
|
I.T. Murkamilov
The relationship between the concentration of fibroblast growth factor-23 and central hemodynamics in patients with chronic kidney disease
|
№1 / 2020
|
|
I.T. Murkamilov, V.V. Fomin, K.A. Aitbaev, Z.R. Rayimzhanov, N.A. Redzhapova, F.A. Yusupov, Z.A. Aydarov
Cytokine model of the development of cardiovascular complications in chronic kidney disease
|
№2 / 2017
|
|
S.E. Khoroshilov
Unresolver problem of calcium in phosphate-binding therapy of bone-mineral metabolism dis-turbances in patients with chronic kidney disease on program hemodialysis
|
№1 / 2014
|
|
V.V. Fomin
Isolated systolic hypertension: global risk factor
|
№1 / 2011
|
|
О.V. Rtyscheva, O.F. Kalev, V. Yu. Akhmatov
Сauses of death in patients receiving program heamodalysis
|
№1 / 2011
|
|
J.S. Milovanov, L.J. Milovanova, L.V. Kozlovskaya
Anaemia in chronic kidney disease: pathogenesis, prognostic sighnificance, treatment
|
№6 / 2010
|
|
Hyperuricemia, arterial hypertension and chronic kidney disease: interconnection and management strategy
|
№4 / 2010
|
|
V.V. Fomin, M.M. Kurashov
From saralasin to sartans: history of the angiotensin II receptor blockade
|
№4 / 2009
|
Русский
